Literature DB >> 12123232

New prognostic parameters for chronic myelomonocytic leukemia.

Ulrich Germing, Corinna Strupp, Manuel Aivado, Norbert Gattermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12123232     DOI： 10.1182/blood-2002-01-0330

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  Making Sense of Prognostic Models in Chronic Myelomonocytic Leukemia.

Authors:  Aziz Nazha; Mrinal M Patnaik
Journal:  Curr Hematol Malig Rep       Date:  2018-10       Impact factor: 3.952

Review 2.  Chronic myelomonocytic leukemia prognostic classification and management: evidence base and current practice.

Authors:  Dorothée Selimoglu-Buet; Eric Solary
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

Review 3.  Chronic myelomonocytic leukemia diagnosis and management.

Authors:  Onyee Chan; Aline Renneville; Eric Padron
Journal:  Leukemia       Date:  2021-03-13       Impact factor: 11.528

4.  Diagnosis and management of chronic myelomonocytic leukemia.

Authors:  Francesco Onida; Miloslav Beran
Journal:  Curr Hematol Malig Rep       Date:  2008-01       Impact factor: 3.952

Review 5.  Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups.

Authors:  Francesco Onida; Giovanni Barosi; Giuseppe Leone; Luca Malcovati; Enrica Morra; Valeria Santini; Giorgina Specchia; Sante Tura
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

Review 6.  Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.

Authors:  Kristen B McCullough; Mrinal M Patnaik
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

Review 7.  Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.

Authors:  Mrinal M Patnaik; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2018-06       Impact factor: 10.047

8.  Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

Authors:  Hien Duong Liu; Kwang Woo Ahn; Zhen-Huan Hu; Mehdi Hamadani; Taiga Nishihori; Baldeep Wirk; Amer Beitinjaneh; David Rizzieri; Michael R Grunwald; Mitchell Sabloff; Richard F Olsson; Ashish Bajel; Christopher Bredeson; Andrew Daly; Yoshihiro Inamoto; Navneet Majhail; Ayman Saad; Vikas Gupta; Aaron Gerds; Adriana Malone; Martin Tallman; Ran Reshef; David I Marks; Edward Copelan; Usama Gergis; Mary Lynn Savoie; Celalettin Ustun; Mark R Litzow; Jean-Yves Cahn; Tamila Kindwall-Keller; Gorgun Akpek; Bipin N Savani; Mahmoud Aljurf; Jacob M Rowe; Peter H Wiernik; Jack W Hsu; Jorge Cortes; Matt Kalaycio; Richard Maziarz; Ronald Sobecks; Uday Popat; Edwin Alyea; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-20       Impact factor: 5.742

Review 9.  Models of Prognostication in Chronic Myelomonocytic Leukemia.

Authors:  Francesco Onida
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

Review 10.  Therapy for Chronic Myelomonocytic Leukemia in a New Era.

Authors:  Tamara K Moyo; Michael R Savona
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.